Cook Pharmica

E. Morrey Atkinson, Ph.D., has joined Cook Pharmica as vice president of R&D and chief scientific officer. Dr. Atkinson will be responsible for guiding the company’s scientific direction, relying on his extensive past experience with process development of gene therapies, vaccines, recombinant proteins and monoclonal antibodies.

“Morrey comes to us with a broad background of scientific and business experience in both the domestic and international marketplace,” said Tedd Green, president of Cook Pharmica. “His broad technical, management and leadership experience will be a great strength to our team and we are proud to welcome him to the Cook organization.”

Dr. Atkinson has almost two decades of experience in biologics development and has held various leadership positions in biotechnology manufacturing and development. Most recently, he was head of biotechnology manufacturing sciences and technology for Eli Lilly and Company in Kinsale, Ireland.

“I look forward to contributing my experience with biologics development to this organization,” Dr. Atkinson said. “With the potential to offer the broadest range of development and production services in the industry, Cook Pharmica has a bright future ahead, and I am excited to join this leadership team.”